Clinical Trials Logo

Atherosclerosis Obliterans clinical trials

View clinical trials related to Atherosclerosis Obliterans.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05473884 Recruiting - In-stent Restenosis Clinical Trials

Lesion Preparation in Femoropopliteal Artery Occlusion Disease

CIVILIAN
Start date: June 1, 2022
Phase:
Study type: Observational [Patient Registry]

Peripheral arterial disease (PAD) carries a significant global health burden, and can limit functional capacity and quality of life. Percutaneous transluminal angioplasty (PTA) for PAD is often associated with suboptimal outcomes due to complications following balloon inflation related to vessel trauma and flow limiting dissections that may require bailout stenting. Different strategies and techniques to enhance both acute and longer-term outcomes with drug-coated balloons (DCB) are needed. This is a national, prospective, multi-center, non-randomized, real-world study to evaluate the safety and efficacy of multiple vessel preparation strategies combined with drug-coating balloon (DCB) in Femoropopliteal Artery (F-PA) lesions.

NCT ID: NCT04440072 Recruiting - Clinical trials for Peripheral Arterial Disease

Comparison of 3 Ultrasonic Techniques for Measuring the Systolic Pressure Index

ABIPULSE
Start date: July 17, 2020
Phase:
Study type: Observational

Continuous Doppler ankle brachial index (ABI) is the gold standard for screening and monitoring of peripheral arterial disease (PAD) but is no longer carried out in clinical practice. The recommended measurement was gradually replaced by colour or pulsed Doppler without validation of these techniques. The objective of our study is to compare these two techniques (color Doppler and pulsed Doppler in echodoppler) with respect to the gold standard (continuous Doppler) for ABI measurement.